Militello John's Form 4 filing
Rocket Pharmaceuticals, Inc. (RCKT) · filed Aug 20, 2025
- Accession no.
- 0001140361-25-032092
- Filed
- Aug 20, 2025
- Trade date
- Aug 18-19, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $3.23K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Militello JohnCIK 0001662170 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | Common Stock | SSaleDisposed | −699 | $3.07 | −$2,145.93 | 56,285 | Direct | |
| Aug 19, 2025 | Common Stock | SSaleDisposed | −361 | $3.00 | −$1,083 | 55,924 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Vice President of Finance, Treasurer, Principal Accounting Officer